BR9405423A - Processo para síntese estereoseletive de nucleosidos análogos usando intermediários bicíclicose - Google Patents

Processo para síntese estereoseletive de nucleosidos análogos usando intermediários bicíclicose

Info

Publication number
BR9405423A
BR9405423A BR9405423A BR9405423A BR9405423A BR 9405423 A BR9405423 A BR 9405423A BR 9405423 A BR9405423 A BR 9405423A BR 9405423 A BR9405423 A BR 9405423A BR 9405423 A BR9405423 A BR 9405423A
Authority
BR
Brazil
Prior art keywords
pct
formula
image
nucleoside analogs
stereoselective synthesis
Prior art date
Application number
BR9405423A
Other languages
English (en)
Inventor
Haolun Jin
Tarek Mansour Evans
Collen A Evans
Arshad M Siddiqui
Allan H L Tse
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Publication of BR9405423A publication Critical patent/BR9405423A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR9405423A 1993-06-07 1994-06-07 Processo para síntese estereoseletive de nucleosidos análogos usando intermediários bicíclicose BR9405423A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939311709A GB9311709D0 (en) 1993-06-07 1993-06-07 Stereoselective synthesis of nucleoside analogues using bicycle intermediate
PCT/CA1994/000311 WO1994029301A1 (en) 1993-06-07 1994-06-07 Stereoselective synthesis of nucleoside analogues using bicyclic intermediate

Publications (1)

Publication Number Publication Date
BR9405423A true BR9405423A (pt) 1999-05-25

Family

ID=10736757

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9405423A BR9405423A (pt) 1993-06-07 1994-06-07 Processo para síntese estereoseletive de nucleosidos análogos usando intermediários bicíclicose

Country Status (22)

Country Link
US (1) US5763606A (pt)
EP (1) EP0654031B1 (pt)
JP (1) JP3110461B2 (pt)
KR (1) KR100304072B1 (pt)
CN (1) CN1046720C (pt)
AT (1) ATE188215T1 (pt)
AU (1) AU668829B2 (pt)
BR (1) BR9405423A (pt)
CA (1) CA2141029C (pt)
DE (1) DE69422374T2 (pt)
DK (1) DK0654031T3 (pt)
ES (1) ES2139744T3 (pt)
FI (1) FI112078B (pt)
GB (1) GB9311709D0 (pt)
HK (1) HK1008673A1 (pt)
HU (1) HU219199B (pt)
NO (1) NO303449B1 (pt)
NZ (1) NZ267379A (pt)
OA (1) OA10349A (pt)
PL (1) PL180870B1 (pt)
RU (1) RU2139870C1 (pt)
WO (1) WO1994029301A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684164A (en) * 1988-04-11 1997-11-04 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
WO1996012716A1 (en) * 1994-10-22 1996-05-02 Chong Kun Dang Corp. Nucleoside derivatives and process for preparing thereof
JP4249393B2 (ja) 1998-08-12 2009-04-02 トライアングル・ファーマシューティカルズ，インコーポレイテッド １，３−オキサチオランヌクレオチドの製造方法
US6979561B1 (en) 1998-10-09 2005-12-27 Gilead Sciences, Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
CA2308559C (en) 2000-05-16 2005-07-26 Brantford Chemicals Inc. 1,3-oxathiolan-5-ones useful in the production of antiviral nucleoside analogues
CN102911166B (zh) * 2001-03-01 2016-08-17 基利得科学公司 顺-ftc的多晶型物及其它晶型
ES2308136T3 (es) * 2003-01-14 2008-12-01 Gilead Sciences, Inc. Composiciones y procedimientos para la politerapia antiviral.
WO2005074654A2 (en) * 2004-02-03 2005-08-18 Emory University Methods to manufacture 1,3-dioxolane nucleosides
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
AU9125991A (en) * 1990-12-05 1992-07-08 University Of Georgia Research Foundation, Inc., The Enantiomerically pure beta -l-(-)-1,3-oxathiolane nucleosides
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
US5332814A (en) * 1991-11-12 1994-07-26 Ciba-Geigy Corporation Process for the preparation of carbacyclic nucleosides, and intermediates

Also Published As

Publication number Publication date
ES2139744T3 (es) 2000-02-16
CN1110479A (zh) 1995-10-18
EP0654031A1 (en) 1995-05-24
KR100304072B1 (ko) 2001-11-22
HU219199B (en) 2001-03-28
JPH08505643A (ja) 1996-06-18
HU9500364D0 (en) 1995-05-29
CN1046720C (zh) 1999-11-24
DE69422374T2 (de) 2000-06-29
OA10349A (en) 2001-10-18
PL180870B1 (pl) 2001-04-30
HK1008673A1 (en) 1999-05-14
RU95108553A (ru) 1996-11-20
NO950432D0 (no) 1995-02-06
DE69422374D1 (de) 2000-02-03
ATE188215T1 (de) 2000-01-15
HUT73630A (en) 1996-08-28
AU668829B2 (en) 1996-05-16
DK0654031T3 (da) 2000-06-13
US5763606A (en) 1998-06-09
GB9311709D0 (en) 1993-07-21
FI112078B (fi) 2003-10-31
CA2141029A1 (en) 1994-12-22
NO303449B1 (no) 1998-07-13
WO1994029301A1 (en) 1994-12-22
FI950535A (fi) 1995-02-07
NZ267379A (en) 1997-04-24
CA2141029C (en) 2000-07-25
EP0654031B1 (en) 1999-12-29
RU2139870C1 (ru) 1999-10-20
NO950432L (no) 1995-03-13
AU6966794A (en) 1995-01-03
PL307350A1 (en) 1995-05-15
JP3110461B2 (ja) 2000-11-20
FI950535A0 (fi) 1995-02-07

Similar Documents

Publication Publication Date Title
TW262474B (pt)
NZ237132A (en) Preparation of substituted oxetanones from beta-hydroxy-omega-lactones; various beta-hydroxy and beta-keto-omega-lactones
BR9405423A (pt) Processo para síntese estereoseletive de nucleosidos análogos usando intermediários bicíclicose
TW366349B (en) Processes for the diastereoselective synthesis of nucleosides
ATE179983T1 (de) Antiretrovirale, enantiomere nukleotid-analoge
Prugh et al. Methyl 3-0-benzyl-2, 4, 6-trideoxy-6-iodo-α-d-erythro-hexopyranoside, a chiral synthon for the synthesis of inhibitors of HMG-CoA reductase
KR880005129A (ko) 신규 화합물
SE9101482D0 (sv) Foerfarande foer framstaellning av mellanprodukter anvaendbara foer syntes av bensotiazepiner
KR910006288A (ko) 신규 제조방법
ATE229011T1 (de) Verfahren zur herstellung von glycidylethern
ATE207908T1 (de) Verfahren zur herstellung von 2-alkoxy-6- (trifluormethyl)-pyrimidin-4-ol
CA2138018A1 (en) Process and Intermediates for Bis-Aza-Bicyclic Anxiolytic Agents
ATE132864T1 (de) Herstellung von dioxolanderivaten
DE69104710D1 (de) Verfahren zur herstellung von uracilderivaten.
ATE342251T1 (de) Verfahren zur herstellung der 2-(dimethylamino)-1-(dimethylaminomethyl)ethyle (methyl)acrylat
KR970042487A (ko) 알칼리 금속을 촉매로 이용한 아크릴산 에스테르 화합물의 제조방법
AR005042A1 (es) Procedimiento para la preparacion de un antagonista endotelin.

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal